BioSpace News Archive

FDA

Jazz Pharma Gets Approval for Zepzelca in the U.S. for Aggressive Lung Cancer

The approval was based on monotherapy clinical data from a trial in 105 adults with SCLC whose disease progressed after platinum-based chemotherapy.

June 16, 2020
·
3 min read
·
Mark Terry
Drug Development

Study: Pfizer’s Experimental Diabetes Drug Robustly Reduces Weight and Glucose

Data presented at the virtual American Diabetes Association meeting has Pfizer excited about the promise of its GLP-1R Agonist PF-06882961.

June 16, 2020
·
2 min read
·
Alex Keown
Business

Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal

Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline.

June 16, 2020
·
3 min read
·
Mark Terry
Drug Development

At Interim Analysis, Lilly’s Verzenio Hits the Mark in High-Risk Breast Cancer Patients

In a Phase III study, Eli Lilly’s Verzenio combined with standard adjuvant endocrine therapy met its primary endpoint of invasive disease-free survival in high-risk breast cancer and significantly reduced the risk of a recurrence of the disease.

June 16, 2020
·
2 min read
·
Alex Keown
Drug Development

Dexamethasone Reduces Deaths in Hospitalized COVID-19 Patients Needing Oxygen, Study Shows

Low doses of a long-used steroid known as dexamethasone could be the solution to improving the chances of patients who become seriously ill from COVID-19 infection and require some kind of breathing assistance.

June 16, 2020
·
2 min read
·
Alex Keown
Policy

FDA Warns Against Co-Administering Remdesivir with Hydroxychloroquine or Chloroquine

The warning came only a few hours after the FDA rescinded Emergency Use Authorization (EUA) for hydroxychloroquine and chloroquine for the treatment of COVID-19.

June 16, 2020
·
4 min read
·
Gail Dutton
Biotech Bay

4DMT to Use $75 Million Series C to Advance Three Key Pipeline Products

Before the end of this year, 4DMT intends to launch clinical trials for 4D-310, its product candidate for the treatment of Fabry disease, and 4D-125 and 4D-110, its two ophthalmology product candidates.

June 16, 2020
·
3 min read
·
Krystle Vermes
Drug Development

Biopharma Update on the Novel Coronavirus: June 17

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.

June 16, 2020
·
5 min read
·
BioSpace Editorial Staff
Business

UM School of Medicine Researchers Help Identify Potent Antibody Cocktail with Potential to Treat COVID-19

Researchers at the University of Maryland School of Medicine evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

June 16, 2020
·
4 min read
Business

GSK Dives Deeper into Synthetic Lethality with IDEAYA Biosciences

The two companies will explore potential oncology treatments with emerging technology.

June 16, 2020
·
2 min read
·
Alex Keown